Picture of BioPorto A/S logo

BIOPOR BioPorto A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Bioporto Q2 Adjusted EBITDA Loss Of DKK 17.1 Mln

Aug 17 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * Q2 ADJUSTED EBITDA LOSS OF DKK 17.1 MILLION / USD 2.5
MILLION
    * Q2 TOTAL REVENUE OF DKK 8.5 MILLION / USD 1.2 MILLION, A
29%
INCREASE OVER PRIOR YEAR
    * MAINTAINS ITS 2022 FINANCIAL GUIDANCE FOR EBIT AND
ADJUSTED
EBITDA
    * GUIDANCE FOR 2022: OPERATING (EBIT) LOSS OF APPROXIMATELY
DKK 95
TO 100 MILLION
    * GUIDANCE 2022: ADJUSTED EBITDA LOSS OF APPROXIMATELY DKK
76 TO
81 MILLION
    * GUIDANCE FOR 2022 UPDATED
    * INCREASES THE UPPER END OF ITS REVENUE GUIDANCE FOR THE
2022
FISCAL YEAR, WITH A NEW RANGE OF DKK 24 TO 27 MILLION
    * THE PREVIOUS RANGE FOR REVENUE GUIDANCE WAS DKK 24 TO 26
MILLION

Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on BioPorto A/S

See all news